Apotheka acquires two pharmacy outlets from Panpharmacy
In a strategic move that signifies the ongoing consolidation and growth within the Latvian pharmaceutical retail sector, Panpharmacy, the parent company of the leading online pharmacy InternetAptieka.lv, has successfully completed the sale of two of its brick-and-mortar pharmacies to Apotheka. These pharmacies, both situated in the capital city of Riga, will continue to serve customers under the Apotheka brand, marking a seamless transition in ownership and operations.
InternetAptieka.lv is recognized as the premier online pharmacy platform in Latvia, offering a wide range of pharmaceutical products and health-related services to its customers. This divestiture allows Panpharmacy to potentially refocus resources and further strengthen its leading position in the digital pharmacy space.
Apotheka is a prominent name in the Latvian pharmaceutical retail landscape. The company currently operates more than 120 pharmacies across Latvia, with a significant presence in Riga as well as major cities such as Liepaja, Ventspils, Jelgava, Daugavpils and Rezekne. Apotheka is part of Magnum Group, a leading group in pharmaceutical wholesaling and retailing in the Baltic States.
Oaklins’ team in Latvia acted as the exclusive M&A advisor to Panpharmacy and its shareholders.
Talk to the deal team
Related deals
The Providence Projects has been acquired by UKAT Group
Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.
Learn moreSt. Claraspital AG has been acquired by University Hospital Basel
University Hospital Basel (USB) has acquired St. Claraspital AG, expanding its network of specialized care and integrated services. With St. Claraspital’s strong community presence, expertise in acute and rehabilitation medicine and established outpatient clinics, this merger enhances USB’s ability to provide seamless, patient-centered treatment across the continuum of care. The completion of the transaction is subject to clearance by the Swiss Competition Commission (COMCO).
Learn moreA share exchange agreement for making NARUMIYA a wholly owned subsidiary of World has been executed
World Co., Ltd. and NARUMIYA INTERNATIONAL Co., Ltd. have entered into a definitive share exchange agreement, under which World will acquire all outstanding shares of NARUMIYA and make it a wholly owned subsidiary. The share exchange is scheduled to take effect on 1 October 2025. Under the terms of the agreement, NARUMIYA shareholders will receive 0.58 shares of World stock for each Narumiya share they hold.
Learn more